Annette Snejbjerg Bartels
Biomedical Laboratory Scientist
Molecular and Cellular Pharmacology
Jagtvej 160, København Ø
1 - 1 out of 1Page size: 10
- 2012
- Published
TIMP-1 in combination with HER2 and TOP2A for prediction of benefit from adjuvant anthracyclines in high-risk breast cancer patients
Hertel, P. B., Tu, D., Ejlertsen, Bent Laursen, Jensen, M. R., Balslev, E., Jiang, S., O'Malley, F. P., Pritchard, K. I., Shepherd, L. E., Bartels, Annette Snejbjerg, Brunner, N. & Nielsen, T. O., 2012, In: Breast Cancer Research and Treatment. 132, 1, p. 225-234 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 6090964
Most downloads
-
864
downloads
TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
849
downloads
High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
687
downloads
Lack of relationship between TIMP-1 tumour cell immunoreactivity, treatment efficacy and prognosis in patients with advanced epithelial ovarian cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Published